Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.


             
 

Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.

Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.

Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.

Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.

Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.



NAVIGATION


         

 

A cost-effectiveness analysis conducted by researchers at Stanford University Hospital in Calif., shows that an initial double-balloon enteroscopy (DBE) is a cost-effective approach for patients with obscure gastrointestinal (GI) bleeding.

 

Given Imaging Ltd. (NASDAQ: GIVN) today announced that the French Ministry of Health has concluded the reimbursement process for PillCam(R) SB and set a pricing level of 418EUR without VAT. The decision was published in the Journal Officiel on November 21, 2008.

 

W. L. Gore & Associates (Gore) today announced at the 35th annual VEITHsymposium™ in New York that it has received regulatory clearance from Health Canada’s Therapeutic Products Directorate to market the GORE EXCLUDER AAA Endoprosthesis and GORE TAG Thoracic Endoprosthesis in Canada. Planning is underway for Canadian physician training on the devices, and the subsequent commercial product release timeline will be announced in the near future.

 

Biohit is extending its range of diagnostic tests for gastrointestinal diseases with ColonView Hb and Hb/Hp quick tests, which are intended to aid early diagnosis and prevention of colorectal cancer. ColonView testing can be used for simple and cost-effective identification of patients with fecal occult blood, which is a well-known marker for colorectal cancer and pre-cancerous large adenomas.

 

A study by researchers in Japan concludes that Double Balloon Endoscopy™ (DBE) was very useful in the diagnosis of obscure gastrointestinal (GI) bleeding and had a therapeutic impact on the majority of patients. The study appears in the October issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).

 

ETT assessment is used to diagnose diseases, such as gastroesophageal reflux, dysphagia, esophagitis, and achalasia. These studies are commonly performed in conjunction with scintigraphic and manometric techniques, despite the use of ionizing radiation and catheters, for each of these additional techniques, respectively. Recently, several types of assessments were performed using the biomagnetic technique, including the assessment of gastric emptying time.

 

At the United European Gastroenterology Federation Annual Scientific Meeting in Vienna, Austria (UEGW Vienna 2008), world-renowned gastroenterologist Jerome D. Waye, MD, principal investigator, presented clinical results from a multi-institutional study which evaluated the efficacy of the Third Eye(R) Retroscope(R).

 

Given Imaging Ltd. (NASDAQ: GIVN) today announced data from a pilot study that demonstrate the Company’s PillCam® capsule endoscopy of the esophagus can significantly reduce health care costs in a prison population through on-site evaluation of esophageal varices in cirrhotic patients.

 

Given Imaging Ltd. (NASDAQ: GIVN) today announced data from a pilot study that demonstrate the Company’s PillCam® capsule endoscopy of the esophagus can significantly reduce health care costs in a prison population through on-site evaluation of esophageal varices in cirrhotic patients.

 

A research article published in the World Journal of Gastroenterology refers to this subject. The research team led by Prof. Serhat Aymaz from Cologne City Hospital presented a new type of stent design for transcardial application, which is intended to prevent bleeding due to mechanical mucosal lesions caused by the distal end of the stent extending into the stomach. They decided to carry out palliative stent implantation to treat the stenosis.




December 2008
Mon Tue Wed Thu Fri Sat Sun
« Nov    
1234567
891011121314
15161718192021
22232425262728
293031